Literature DB >> 20977918

Interleukin-21 and cellular activation concurrently induce potent cytotoxic function and promote antiviral activity in human CD8 T cells.

Anita Parmigiani1, Maria F Pallin, Helena Schmidtmayerova, Mathias G Lichtenheld, Savita Pahwa.   

Abstract

Infection with human immunodeficiency virus (HIV)-1 induces a progressive deterioration of the immune system that ultimately leads to acquired immune deficiency syndrome (AIDS). Murine models indicate that the common γ-chain (γ(c))-sharing cytokine interleukin (IL)-21 and its receptor (IL-21R) play a crucial role in maintaining polyfunctional T cell responses during chronic viral infections. Therefore, we analyzed the ability of this cytokine to modulate the properties of human CD8 T cells in comparison with other γ(c)-sharing cytokines (IL-2, IL-7, and IL-15). CD8 T cells from healthy volunteers were stimulated in vitro via T cell receptor signals to mimic the heightened status of immune activation of HIV-infected patients. The administration of IL-21 upregulated cytotoxic effector function and the expression of the costimulatory molecule CD28. Notably, this outcome was not accompanied by increased cellular proliferation or activation. Moreover, IL-21 promoted antiviral activity while not inducing HIV-1 replication in vitro. Thus, IL-21 may be a favorable molecule for immunotherapy and a suitable vaccine adjuvant in HIV-infected individuals. Copyright Â
© 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20977918      PMCID: PMC3042849          DOI: 10.1016/j.humimm.2010.10.015

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  57 in total

1.  The precursors of memory: models and controversies.

Authors:  Rafi Ahmed; Michael J Bevan; Steven L Reiner; Douglas T Fearon
Journal:  Nat Rev Immunol       Date:  2009-08-14       Impact factor: 53.106

2.  CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells.

Authors:  Nichole R Klatt; Emi Shudo; Alex M Ortiz; Jessica C Engram; Mirko Paiardini; Benton Lawson; Michael D Miller; James Else; Ivona Pandrea; Jacob D Estes; Cristian Apetrei; Joern E Schmitz; Ruy M Ribeiro; Alan S Perelson; Guido Silvestri
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

3.  In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells.

Authors:  Joseph K Wong; Matthew C Strain; Rodin Porrata; Elizabeth Reay; Sumathi Sankaran-Walters; Caroline C Ignacio; Theresa Russell; Satish K Pillai; David J Looney; Satya Dandekar
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

4.  Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study.

Authors:  Alexandre Iannello; Mohamed-Rachid Boulassel; Suzanne Samarani; Olfa Debbeche; Cécile Tremblay; Emil Toma; Jean-Pierre Routy; Ali Ahmad
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

5.  Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells.

Authors:  Matthew E Pipkin; Jilian A Sacks; Fernando Cruz-Guilloty; Mathias G Lichtenheld; Michael J Bevan; Anjana Rao
Journal:  Immunity       Date:  2010-01-21       Impact factor: 31.745

6.  Interleukin-2 therapy in patients with HIV infection.

Authors:  D Abrams; Y Lévy; M H Losso; A Babiker; G Collins; D A Cooper; J Darbyshire; S Emery; L Fox; F Gordin; H C Lane; J D Lundgren; R Mitsuyasu; J D Neaton; A Phillips; J P Routy; G Tambussi; D Wentworth
Journal:  N Engl J Med       Date:  2009-10-15       Impact factor: 91.245

7.  IL-21R on T cells is critical for sustained functionality and control of chronic viral infection.

Authors:  Anja Fröhlich; Jan Kisielow; Iwana Schmitz; Stefan Freigang; Abdijapar T Shamshiev; Jacqueline Weber; Benjamin J Marsland; Annette Oxenius; Manfred Kopf
Journal:  Science       Date:  2009-05-28       Impact factor: 47.728

8.  Induction of granulysin in CD8+ T cells by IL-21 and IL-15 is suppressed by human immunodeficiency virus-1.

Authors:  A E Hogg; G C Bowick; N K Herzog; M W Cloyd; J J Endsley
Journal:  J Leukoc Biol       Date:  2009-08-17       Impact factor: 4.962

9.  In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients.

Authors:  Laurence Weiss; Fabrice A Letimier; Matthieu Carriere; Sylvie Maiella; Vladimira Donkova-Petrini; Brice Targat; Arndt Benecke; Lars Rogge; Yves Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

10.  IL-21 enhances NK cell functions and survival in healthy and HIV-infected patients with minimal stimulation of viral replication.

Authors:  Alexandre Iannello; Mohamed-Rachid Boulassel; Suzanne Samarani; Cécile Tremblay; Emil Toma; Jean-Pierre Routy; Ali Ahmad
Journal:  J Leukoc Biol       Date:  2010-01-26       Impact factor: 4.962

View more
  24 in total

1.  The proportion of different interleukin-17-producing T-cell subsets is associated with liver fibrosis in chronic hepatitis C.

Authors:  Fabio C O F Cachem; Aleida S Dias; Clarice Monteiro; José Roberto Castro; Gabriel Fernandes; Letícia Delphim; Adilson J Almeida; Felipe Tavares; Alessandra M A Maciel; Marcia M Amendola-Pires; Carlos E Brandão-Mello; Cleonice A M Bento
Journal:  Immunology       Date:  2017-03-13       Impact factor: 7.397

Review 2.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

Review 3.  Attacking the HIV reservoir from the immune and viral perspective.

Authors:  Marta Massanella; Javier Martinez-Picado; Julià Blanco
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

Review 4.  The role of interleukin-21 in HIV infection.

Authors:  Suresh Pallikkuth; Anita Parmigiani; Savita Pahwa
Journal:  Cytokine Growth Factor Rev       Date:  2012-07-02       Impact factor: 7.638

5.  Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication.

Authors:  Suresh Pallikkuth; Kenneth Rogers; Francois Villinger; Melvin Dosterii; Monica Vaccari; Genoveffa Franchini; Rajendra Pahwa; Savita Pahwa
Journal:  Vaccine       Date:  2011-10-11       Impact factor: 3.641

Review 6.  T cell replicative senescence in human aging.

Authors:  Jennifer P Chou; Rita B Effros
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 7.  Signal transducer and activator of transcription 3: a year in review.

Authors:  Lisa R Forbes; Josh Milner; Elie Haddad
Journal:  Curr Opin Hematol       Date:  2016-01       Impact factor: 3.284

Review 8.  Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines.

Authors:  Morgan A Reuter; Carolina Pombo; Michael R Betts
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

Review 9.  Anti-viral CD8 T cells and the cytokines that they love.

Authors:  Maureen A Cox; Shannon M Kahan; Allan J Zajac
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

10.  Interleukin-21 responses in patients with chronic hepatitis B.

Authors:  Jie Li; Wanhua Ren; Wei Ma; Jiao Zhang; Jun Shi; Chengyong Qin
Journal:  J Interferon Cytokine Res       Date:  2014-09-22       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.